Royalty Pharma (RPRX) Fails to deliver data

Key failure to deliver metrics for Royalty Pharma:

• Last SEC data release: 2025-11-28
• Last 15 days FTD volume: HK$17.14 M
• Last 3 months FTD volume: HK$0.16 B
• Last 12 months FTD volume: HK$0.22 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Royalty Pharma (RPRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Royalty Pharma (RPRX) - since 2020

Royalty Pharma (RPRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
ANI Pharmaceuticals ANIP	HK$2.97 M	HK$6.57 M	🇺🇸 USA
Abbott Laboratories ABT	HK$34.98 M	HK$0.43 B	🇺🇸 USA
Eli Lilly LLY	HK$0.29 B	HK$0.42 B	🇺🇸 USA